224 articles in this topic
Comprehensive review reveals estrogen-only therapy carries lower breast cancer risk than combined hormone treatments during menopause.
Three-month romosozumab protocol offers pragmatic solution for osteoporosis treatment with potentially improved patient outcomes.
Three months of romosozumab plus denosumab matched 12 months of romosozumab alone for bone strength gains in postmenopausal women.
New research reveals how diabetes and obesity trigger bone inflammation and disrupt key signaling pathways, increasing fracture risk in older women.
New research reveals which bariatric surgery works best and identifies patient factors that predict long-term success.
New research reveals cardiovascular-kidney-metabolic syndrome stages predict cancer risk through inflammatory pathways.
Advanced incretin-based therapies show potential for major weight loss while protecting heart, kidney, liver, and brain health.
New genetic analysis reveals how brain and fat tissue work together to regulate obesity and cardiovascular health.
Natural polyketide from marine bacteria enhances cholesterol removal and improves fat metabolism in liver cells and mice.
Scientists identify how a metabolic enzyme drives kidney inflammation in diabetes, opening doors for targeted therapies.
Breakthrough study reveals sepiapterin dramatically outperforms existing PKU therapy, offering hope for better metabolic control.
New research reveals how liver fat accumulation triggers cardiovascular disease through multiple pathways.
